RX-TO-OTC SWITCH AND DOUBLE REGISTRATION OCCURRENCE IN POLAND--AN ILLUMINATIVE CASE STUDY

Area of Science:

• Pharmaceutical Law
• Public Health Policy

Background:

• The Rx-to-OTC switch aims to empower patients in self-treating minor ailments, potentially reducing healthcare expenditures.
• However, improper use or abuse of OTC medications can lead to adverse effects and increased treatment costs.
• Interactions between OTC drugs and existing medications for chronic conditions pose a safety risk.

Purpose of the Study:

• To examine the implications of Rx-to-OTC switches on patient safety and healthcare systems.
• To explore the potential role of pharmacists in ensuring safe self-treatment.
• To provide a legal case study for establishing a pharmacist-only drug classification.

Main Methods:

• Analysis of current pharmaceutical legislation and policies.
• Review of potential risks and benefits associated with OTC drug access.
• Case study approach to evaluate existing legal frameworks.

Main Results:

• The Rx-to-OTC switch presents both opportunities for cost reduction and challenges in patient safety.
• Increased pharmacist involvement is crucial for mitigating risks associated with self-medication.
• Existing legal structures may need adaptation to accommodate new drug access models.

Conclusions:

• Establishing a pharmacist-only drug class could enhance patient safety and optimize self-treatment.
• A balanced approach is needed to leverage the benefits of OTC access while managing potential harms.
• Further discussion and legislative review are necessary to implement such a classification effectively.